MRK | Merck & Co., Inc. | $292.0b | $110.34 | -1.4% | 9.2M |
GILD | Gilead Sciences Inc | $169.2b | $127.72 | -2.1% | 8.2M |
PFE | Pfizer Inc. | $158.0b | $26.85 | -0.6% | 34.8M |
MRNA | Moderna, Inc. Common Stock | $19.1b | $48.68 | -4.0% | 6.1M |
SMMT | Summit Therapeutics Inc. Common Stock | $13.2b | $22.13 | +0.2% | 3.7M |
PCVX | Vaxcyte, Inc. Common Stock | $7.9b | $59.77 | +0.5% | 1.0M |
BCRX | BioCryst Pharmaceuticals Inc | $2.4b | $8.91 | -0.3% | 3.1M |
VIR | Vir Biotechnology, Inc. Common Stock | $1.4b | $10.64 | +2.7% | 1.8M |
NVAX | Novavax Inc | $1.3b | $8.07 | -1.8% | 2.7M |
ABUS | Arbutus Biopharma Corporation Common Stock | $0.8b | $4.28 | +1.8% | 5.1M |
CRMD | CorMedix Inc. | $0.5b | $7.83 | +5.5% | 1.7M |
ASMB | Assembly Biosciences, Inc | $422.6m | $27.51 | -1.3% | 49.3K |
EBS | Emergent Biosolutions, Inc. | $415.7m | $7.99 | -0.5% | 456.1K |
AVIR | Atea Pharmaceuticals, Inc. Common Stock | $404.7m | $5.35 | -2.2% | 187.8K |
SIGA | SIGA Technologies Inc. | $376.8m | $4.57 | -0.1% | 419.5K |
ENTA | Enanta Pharmaceuticals, Inc | $353.5m | $13.31 | 0.0% | 92.4K |
IVVD | Invivyd, Inc. Common Stock | $336.3m | $1.47 | +0.7% | 1.2M |
ARMP | Armata Pharmaceuticals, Inc. Common Stock | $314.7m | $10.95 | -15.2% | 192.8K |
ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $196.1m | $8.31 | -3.3% | 253.8K |
TNXP | Tonix Pharmaceuticals Holding Corp. | $161.3m | $12.84 | +1.8% | 236.4K |
SPRO | Spero Therapeutics, Inc. Common Stock | $129.7m | $2.68 | -2.2% | 322.7K |
ANTX | AN2 Therapeutics, Inc. Common Stock | $124.4m | $4.79 | +10.4% | 618.7K |
INO | Inovio Pharmaceuticals, Inc. | $115.4m | $1.18 | +2.6% | 2.9M |
MCRB | Seres Therapeutics, Inc. | $84.4m | $7.30 | -9.9% | 123.2K |
XBIT | XBiotech Inc | $69.2m | $2.59 | +3.2% | 33.1K |
IBO | Impact BioMedical, Inc. | $63.1m | $0.66 | +1.1% | 35.4K |
ZTEK | Zentek Ltd. Common Stock | $55.4m | $0.47 | -0.0% | 64.2K |
ALGS | Aligos Therapeutics, Inc. Common Stock | $40.6m | $6.52 | +1.9% | 140.2K |
ATOS | Atossa Therapeutics, Inc. Common Stock | $40.6m | $5.49 | -3.7% | 36.8K |
SCYX | SCYNEXIS, Inc. | $35.3m | $1.02 | +0.5% | 156.2K |
NNVC | NanoViricides Inc. | $18.8m | $1.24 | -1.6% | 326.2K |
TVGN | Tevogen Bio Holdings Inc. Common Stock | $17.4m | $6.92 | -8.3% | 24.7K |
TRAW | Traws Pharma, Inc. Common Stock | $14.0m | $1.13 | -2.6% | 323.8K |
COCP | Cocrystal Pharma, Inc. Common Stock | $13.8m | $1.41 | -1.4% | 106.7K |
PLRZ | Polyrizon Ltd. Ordinary Shares | $12.4m | $15.99 | +2.8% | 67.0K |
MBRX | Moleculin Biotech, Inc. | $12.0m | $2.55 | +0.4% | 103.2K |
SNGX | Soligenix, Inc. Common Stock | $11.2m | $1.42 | +2.2% | 115.7K |
ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $10.0m | $2.05 | +3.5% | 155.3K |
IMNN | Imunon, Inc. Common Stock | $9.8m | $2.79 | +0.2% | 18.4K |
PHGE | BiomX Inc. | $7.2m | $1.08 | -2.7% | 162.5K |
APM | Aptorum Group Limited Class A Ordinary Shares | $6.8m | $0.94 | +4.2% | 29.3K |
XBIO | Xenetic Biosciences, Inc. | $6.1m | $3.03 | -0.7% | 10.5K |
SBFM | Sunshine Biopharma Inc. | $5.0m | $0.98 | -2.0% | 36.8K |
ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $3.7m | $1.61 | -1.2% | 51.0K |
CODX | Co-Diagnostics, Inc. Common Stock | $3.6m | $1.67 | 0.0% | 56.5K |
AEMD | AETHLON MEDICAL INC | $3.3m | $2.17 | -1.1% | 5.2K |
GOVX | GeoVax Labs, Inc. New | $3.0m | $1.11 | +1.8% | 39.7K |
AIM | AIM ImmunoTech Inc. | $2.3m | $0.53 | +2.1% | 237.8K |
VRAX | Virax Biolabs Group Limited Ordinary Shares | $1.2m | $0.14 | -14.1% | 828.5K |